These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29697277)

  • 1. Urinary biomarkers reporting weakness and validation failure in Type 2 diabetic nephropathy: systematic review.
    Siddiqui K; Joy SS; Ilias S; Alzeer HS; Al-Rubeaan K
    Biomark Med; 2018 May; 12(5):487-499. PubMed ID: 29697277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review.
    Hellemons ME; Kerschbaum J; Bakker SJ; Neuwirt H; Mayer B; Mayer G; de Zeeuw D; Lambers Heerspink HJ; Rudnicki M
    Diabet Med; 2012 May; 29(5):567-77. PubMed ID: 21913962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes.
    Wu J; Shao X; Lu K; Zhou J; Ren M; Xie X; Liu J; Xu Y; Ding Y; Shen X; Zhu C
    Cell Physiol Biochem; 2017; 42(2):594-602. PubMed ID: 28954270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients.
    Al-Rubeaan K; Siddiqui K; Al-Ghonaim MA; Youssef AM; Al-Sharqawi AH; AlNaqeb D
    Sci Rep; 2017 Jun; 7(1):2684. PubMed ID: 28577020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: A systematic review and meta-analysis.
    Chen YL; Qiao YC; Xu Y; Ling W; Pan YH; Huang YC; Geng LJ; Zhao HL; Zhang XX
    Immunol Lett; 2017 Jun; 186():52-58. PubMed ID: 28414180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of urinary proteomic patterns for type 2 diabetic nephropathy by ProteinChip.
    Wu J; Chen YD; Yu JK; Shi XL; Gu W
    Diabetes Res Clin Pract; 2011 Feb; 91(2):213-9. PubMed ID: 21237525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
    El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
    IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into predicting diabetic nephropathy using urinary biomarkers.
    Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
    Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary peptidomics provides a noninvasive humanized readout of diabetic nephropathy in mice.
    Klein J; Ramirez-Torres A; Ericsson A; Huang Y; Breuil B; Siwy J; Mischak H; Peng XR; Bascands JL; Schanstra JP
    Kidney Int; 2016 Nov; 90(5):1045-1055. PubMed ID: 27528550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis.
    Ioannou K
    Hormones (Athens); 2017 Oct; 16(4):351-361. PubMed ID: 29518755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary IgG4 and Smad1 Are Specific Biomarkers for Renal Structural and Functional Changes in Early Stages of Diabetic Nephropathy.
    Doi T; Moriya T; Fujita Y; Minagawa N; Usami M; Sasaki T; Abe H; Kishi S; Murakami T; Ouchi M; Ichien G; Yamamoto K; Ikeda H; Koezuka Y; Takamatsu N; Shima K; Mauer M; Nagai K; Tominaga T
    Diabetes; 2018 May; 67(5):986-993. PubMed ID: 29490904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications.
    Lepedda AJ; De Muro P; Capobianco G; Formato M
    J Diabetes Complications; 2017 Jan; 31(1):149-155. PubMed ID: 27842978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system.
    Vitova L; Tuma Z; Moravec J; Kvapil M; Matejovic M; Mares J
    BMC Nephrol; 2017 Mar; 18(1):112. PubMed ID: 28359252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
    Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
    J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.